CWVCX
Price
$21.39
Change
+$0.06 (+0.28%)
Updated
Dec 2 closing price
Net Assets
866.48M
RERBX
Price
$61.23
Change
+$0.11 (+0.18%)
Updated
Dec 2 closing price
Net Assets
134.01B
Interact to see
Advertisement

CWVCX vs RERBX

Header iconCWVCX vs RERBX Comparison
Open Charts CWVCX vs RERBXBanner chart's image
Calvert International Equity C
Price$21.39
Change+$0.06 (+0.28%)
VolumeN/A
Net Assets866.48M
American Funds EUPAC R2
Price$61.23
Change+$0.11 (+0.18%)
VolumeN/A
Net Assets134.01B
CWVCX vs RERBX Comparison Chart in %
View a ticker or compare two or three
VS
CWVCX vs. RERBX commentary
Dec 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWVCX is a StrongBuy and RERBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 134B vs. CWVCX (866M). CWVCX pays higher dividends than RERBX: CWVCX (0.48) vs RERBX (0.23). CWVCX was incepted earlier than RERBX: CWVCX (32 years) vs RERBX (24 years). CWVCX (1.95) is less costly to investors than RERBX (1.56). RERBX is a more actively managed with annual turnover of: 35.00 vs. CWVCX (23.00). RERBX has a lower initial minimum investment than CWVCX: RERBX (250) vs CWVCX (1000). RERBX annual gain was more profitable for investors over the last year : 11.44 vs. CWVCX (10.84). CWVCX return over 5 years is better than : 11.95 vs. RERBX (-1.22).
CWVCXRERBXCWVCX / RERBX
Total Expense Ratio1.891.56121%
Annual Report Gross Expense Ratio1.951.56125%
Fund Existence32 years24 years-
Gain YTD15.04920.41374%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets866M134B1%
Annual Yield % from dividends0.480.23207%
Returns for 1 year10.8411.4495%
Returns for 3 years25.3426.9894%
Returns for 5 years11.95-1.22-982%
Returns for 10 years60.6635.86169%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPRB89.206.09
+7.33%
Spruce Biosciences Inc
ROKU98.261.74
+1.80%
Roku
HCKT18.810.12
+0.64%
Hackett Group
RKDA3.67-0.03
-0.80%
Arcadia Biosciences
VNET8.77-0.20
-2.23%
VNET Group